Technical analysis of Fortrea Holdings Inc. (FTRE): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Fortrea Holdings Inc. functions as a global contract research organization (CRO), concentrating on providing development services for biopharmaceutical products and medical devices. The company's operations are divided into two main segments: Clinical Services and Enabling Services. Its Clinical Services division offers support across the entire spectrum of clinical pharmacology and development.
Price Performance
| 1 month | +6.45% |
| 3 months | +18.34% |
| Year-to-date | +23.42% |
| 1 year | +103.54% |
| 3 years | -28.68% |
52-Week Range
| 52-week High | $26.16 |
| 52-week Low | $8.55 |
| Avg Volume (90d) | 1.6M |
Technical Indicators
| SMA 50 | $20.28 |
| SMA 200 | $15.70 |
| Beta | 1.77 |
| 30-day Volatility (annualised) | 58.4% |
| Price vs SMA 50 | +5.0% |
| Price vs SMA 200 | +35.6% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-12 | $17.25 | |
| 2026-01 | $16.81 | -2.6% |
| 2026-02 | $10.72 | -36.2% |
| 2026-03 | $9.42 | -12.1% |
| 2026-04 | $11.50 | +22.1% |
| 2026-05 | $15.39 | +33.8% |
| 2026-06 | $17.40 | +13.1% |
| 2026-07 | $19.17 | +10.2% |
| 2026-08 | $18.37 | -4.2% |
| 2026-09 | $19.95 | +8.6% |
| 2026-10 | $21.29 | +6.7% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2027-02-25 | $0.20 | $674M |
| 2026-10-29 | $0.22 | $672M |
| 2026-07-29 | $0.18 | $648M |
| 2026-05-05 | $0.03 | $629M |
| 2026-02-26 | $0.16 | $665M |
| 2025-11-05 | $0.16 | $665M |
| 2025-08-06 | $0.06 | $623M |
Price
| Price | $21.29 (closing price, October 30, 2026) |
| Market Cap | $2.0B |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 3.82 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 2.10 |
| Current Ratio | 0.97 |
| Piotroski F-Score | 3 |
| Altman Z-Score | 0.68 |